Filiz Akyüz

A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease

Manuel Romero‐Gómez, Eric Lawitz, R. Ravi Shankar et al. · Journal of Hepatology · 2023 · 192 citations · Full text

Medicine, Endocrinology, Pharmacology +17

The effect of liver test abnormalities on the prognosis of COVID-19

Alpay Medetalibeyoğlu, Yunus Çatma, Naci Şenkal et al. · Annals of Hepatology · 2020 · 84 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +17

Turkish inappropriate medication use in the elderly (TIME) criteria to improve prescribing in older adults: TIME-to-STOP/TIME-to-START

Gülistan Bahat, Birkan İlhan, Tuğba Erdoğan et al. · European Geriatric Medicine · 2020 · 74 citations · Full text

Pharmacy, Geriatric Medicine, Pharmacotherapy +14

Are Acquired Hepatocerebral Degeneration and Hepatic Myelopathy Reversible?

Sabahattin Kaymakoğlu, Zeliha Matur, Filiz Akyüz et al. · Journal of Clinical Gastroenterology · 2009 · 59 citations

Medicine, Neurology, Pediatrics +17

Evidence of Prostate-Specific Membrane Antigen Expression in Hepatocellular Carcinoma Using 68Ga-PSMA PET/CT

Serkan Kuyumcu, Duygu Has-Şimsek, Fikret Büyükkaya et al. · Clinical Nuclear Medicine · 2019 · 52 citations

Medicine, Nuclear Medicine, Oncology +17